about
Structural and Computational Biology in the Design of Immunogenic Vaccine AntigensFrom Immunologically Archaic to Neoteric Glycovaccines.Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.Adjuvants for vaccines to drugs of abuse and addiction.Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.Structural basis for fragmenting the exopolysaccharide of Acinetobacter baumannii by bacteriophage ΦAB6 tailspike protein.Glycoconjugate vaccines: an update.Towards the next generation of biomedicines by site-selective conjugation.The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production.Potential targets for next generation anti-microbial glycoconjugate vaccines.A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens.
P2860
Q26777382-B717C728-96EC-40F0-8A32-134B52E1F0ECQ30238724-9D087CED-A27B-4C41-B5CA-1B8816F2FB66Q30279061-88602DB9-885D-4660-B67B-4FB7797BC685Q34066431-56FE48CF-F9F8-47C9-A2F3-54A315E0126CQ35493923-AF454BFF-F9F0-4276-9FD2-4818C3BE999AQ37340824-E73A9A85-359B-4A09-A615-36062C4AE588Q37648715-6216C476-D64F-4406-8139-D027C2396C33Q38286346-89B40D82-7C15-4293-A9C6-2CB651B5A9DAQ38706553-C0345CC9-A8B7-4A11-812F-41D49885767FQ40628911-E43EF560-BBE4-4032-BB54-A35F8FA6C474Q46027898-BDE4A6BD-60BE-4301-AFFF-8BD5C95EE619Q47170219-CD5B0618-1A35-4A6E-B033-0A6BECBB9813Q47301550-06EB86E1-2996-4DD9-B9D8-288E377F1041Q53701548-B4BBACB5-5DB0-4047-8A07-7116E2BA1588Q55212962-7F13C768-114E-45EF-BB19-84A3AB9C8CA5
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glycoconjugate vaccines.
@en
type
label
Glycoconjugate vaccines.
@en
prefLabel
Glycoconjugate vaccines.
@en
P2860
P1476
Glycoconjugate vaccines
@en
P2093
David Pace
P2860
P356
10.1517/14712598.2012.725718
P407
P50
P577
2012-09-20T00:00:00Z